Related Experiment Video
Updated: Aug 8, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
[Early diagnosis of lung cancer]
Xue-Zhong Xing1, Yan-Ning Gao, De-Chao Zhang
1Department of Thoracic Surgery, Cancer Hospital and Institute, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100021, PR China.
Abstract:
Lung cancer is one of the leading causes of cancer death in mankind, with five-year survival rate remains 10%. Previous screening trials using chest radiography and cytological examination of sputum failed to reach the goal of a diagnostic screening test,a decrease in lung cancer mortality. With the development of new kinds of technology, there has been a resurgent interest in screening for lung cancer. We reviewed recent diagnosis of early detection of lung cancer including low-dose CT, Thin-Prep cytology, laser- induced fluorescence endoscope and molecular pathology.

